To investigate the degree and specificity of trastuzumab uptake into Fo2-1282 brain grafts, tumor-bearing mice were administered a single systemic dose of either 89Zr-trastuzumab or control 89Zr-anti-STEAP1, then subjected to PET imaging. Here, STEAP1 is linked to neoplasm.